Ironwood Pharmaceuticals, Inc.

NASDAQ:IRWD

3.74 (USD) • At close January 15, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018201720162015201420132012201120102009200820072006
Operating Activities:
Net Income -1,002.239175.065528.448106.17621.505-282.368-116.937-81.708-142.669-189.618-272.812-72.624-64.852-56.411-73.312-55.031-53.16-37.18
Depreciation & Amortization 1.5751.4181.5233.5645.5814.22314.61711.2611.6312.33111.72911.3259.9996.1615.252.8491.7311.259
Deferred Income Tax 72.63765.739-333.2946.59935.934159.1147.534-7.30928.48421.4961.86400.007-5.4950.97-0.001-0.0010
Stock Based Compensation 32.00527.04822.28131.17531.27843.97733.8229.21925.46926.18419.82917.57311.7327.4965.2442.7941.1540
Change In Working Capital 11.2792.8217.731-0.941-99.9937.616-21.788-5.018-38.239-30.1-35.684-27.084-34.357-21.26958.2120.66245.2412.14
Accounts Receivables 0.9247.9937.7124.091-68.8931.207-17.303-10.336-28.679-23.68-1.726-0.8352.2432.324-0.46518.387-24.277-0.697
Inventory 0000.6480.725-0.8060.3461.2673.653-3.078-11.915-6.6991.291-9.2561.714000
Accounts Payables 12.38-8.116-2.644-7.523-32.78.057-6.84319.683-1.5511.425-11.72424.2415.0862.741.57400-0.178
Other Working Capital -2.0252.94312.6631.8430.875-0.8422.012-15.632-11.662-4.767-10.319-43.791-42.977-17.07755.3872.27569.5183.015
Other Non Cash Items 1,068.171.67325.20622.26316.421-13.444-16.80928.1238.3984.1391.7191.1772.2341.619-0.360.532-1.7240.249
Operating Cash Flow 183.427273.763261.895168.83610.725-70.882-99.563-25.433-106.927-155.568-273.355-69.633-75.237-67.899-3.998-28.195-6.759-33.532
Investing Activities:
Investments In Property Plant And Equipment -0.273-0.136-0.265-1.842-7.189-8.621-4.211-104.206-4.049-3.538-9.592-13.979-9.682-17.22-4.045-22.934-2.651-2.822
Acquisitions Net -1,026.0450000.2681.5630.1351000.14700009.50000.001
Purchases Of Investments 00000-3.241-191.354-311.116-281.958-253.995-287.943-96.709-97.511-441.799-26.673-82.613-87.839-36.994
Sales Maturities Of Investments 0000099.165346.89237.423276.707200.964196.102140.757222.254236.47548.45590.46562.8834.2
Other Investing Activites 0000-4.2231.5630.135-99.7750.147-53.031-91.8410.0090.0040.0020.0210.0090.0010
Investing Cash Flow -1,026.318-0.136-0.265-1.842-11.14488.866151.46-177.674-9.153-56.569-101.43330.078115.065-213.04217.758-15.073-27.609-5.615
Financing Activities:
Debt Repayment 300-120.699007.205-1.8248.758-28.771321.67-2.225174.232-0.275-0.26-1.9571.141-1.2150.72-1.939
Common Stock Issued 6.3570018.54613.59532.06126.3724.84114.196190.428137.76685.2280203.16740.250075.027
Common Stock Repurchased 0-126.394-24.131000000000000000
Dividends Paid 000000000000000000
Other Financing Activities -22.849.5419.58118.546-8.3931.89611.07724.595-18.622.7411.584.023.3931.74640.52249.77849.9987.002
Financing Cash Flow 277.16-237.553-4.5518.546-1.18530.07219.835-4.176303.07210.944313.57888.9733.133202.95641.66348.56350.71880.09
Other Information:
Effect Of Forex Changes On Cash -0.05300000000000000000
Net Change In Cash -565.78436.074257.08185.54-1.60448.05671.732-207.283186.99-1.193-61.2149.41842.961-77.98555.4235.29516.350
Cash At End Of Period 92.154657.938621.864364.784179.244180.848125.73654.004261.28774.29775.49136.787.28244.321123.14567.72262.4270